Report Events

[Registration Closed] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)

[Registration Closed] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)

Health and Global Policy Institute (HGPI) will hold a global expert meeting “Toward Equitable Patient Access to Genomic Cancer Medicine” on 4th April.

In the field of oncology, “Cancer Genomic Medicine” has already been actively adopted into routine clinical practice in some countries. There are high expectations that cancer genomic medicine has the potential to fundamentally change the cancer treatment strategy for individual patients in the future.

In Japan, with the insurance coverage of comprehensive genomic profiling in 2019, clinical experience has been accumulating, and the momentum for genomic cancer medicine has been growing since the enactment of the Genomic Medicine Act in June 2023. However, there are some challenges in cancer precision medicine, eg.) regional disparities in patient access to genomic cancer medicine, financial challenges, limited options for treatment based on the genomic testing, etc.

In the UK, various initiatives have been implemented to ensure equitable patient access to genomic testing and research outcomes. These include the formulation of a 5-year strategy to accelerate the use of genomic medicine in routine clinical practice, as well as the establishment of collaborative groups involving patient and public participation. Ensuring equitable patient access to cancer genomic medicine, including cancer genetic panel testing and subsequent treatment, has become a global topic of discussion. Efforts are being made to address this common challenge while maintaining an advanced healthcare system, with policies being implemented accordingly.

In light of the above, HGPI will invite national and international stakeholders to a Global Expert Meeting to share and disseminate issues and best practices in each country regarding equitable patient access to genomic cancer medicine.

 

 

 

[Event Overview] 

  • Date & Time: Thursday, April 4, 2024; from 15:30 to 19:00 JST / from 7:30 to 11:00 GMT (Open: 15:00 JST / 7:00 GMT)
  • Format: Hybrid (In-Person and Online (Zoom Webinars))
  • Venue: Global Business Hub Tokyo Field
    (Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo, JAPAN 100-0004)
  • Languages: Japanese and English (with simultaneous interpretation)
  • Participation fee: Free
  • Hosted by: Health and Global Policy Institute
  • Supported by: The British Embassy Tokyo
  • Sponsored by: AstraZeneca K.K., National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP), Philips Japan, Ltd.
  • Capacity: Venue 50, Online no limit

*Registration in In-Person will close at 12:00, April 1. Participants will be selected by lot and will be informed of the result on April 2. We appreciate your understanding.

**After your registration is completed, a confirmation e-mail will be sent automatically to your e-mail address. If you do not receive it, please send us an e-mail at info@hgpi.org.

***For those who have registered for in-person participation but are unable to attend due to the lottery results, we will handle online registration on our end and provide instructions on the Zoom Webinar link through the system.

 

[Program] (Titles omitted; in no particular order)

15:30-15:40 Opening Remarks
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute)
15:40-16:00 Keynote Speech 1: Genomic Cancer Medicine in Japan
Hitoshi Nakagama (President, National Cancer Center)
16:00-16:20 Keynote Speech 2: Genomic Cancer Medicine in the UK
Dame Sue Hill (Chief Scientific Officer, England and Senior Responsible Officer for Genomics, NHS)
– Break (10 mins) –
16:30-17:10 Round Table Discussion 1
“Tackling Regional Disparities in Patient Access to Genomic Cancer Medicine”

Panelists
Shinsuke Amano (President, National Federation of Cancer Patients Associations /President, Group Nexus Japan)
Masaru Sunagawa (Senior Professor, Department of Clinical Oncology, St. Marianna University School of Medicine)
Masami Sakoi (Chief Medical and Global Health Officer, Ministry of Health, Labour and Welfare)
TBD (Genomic England)

Moderator
Shu Suzuki (Senior Associate, Health and Global Policy Institute)

17:10-17:50 Round Table Discussion 2
“Optimizing Financial and Institutional Support for Innovation”

Panelists
Naomi Sakurai (CEO, CANCER SOLUTIONS)
Hitoshi Nakagama (President, National Cancer Center)
Tamayo Marukawa (Member of the House of Councilors / Executive Acting Chairperson of the Diet Members Caucus for the Development of a Social Environment for the Advancement of Appropriate Genetic Medicine)
TBD

Moderator
Haruka Sakamoto (Senior Manager, Health and Global Policy Institute)

17:50-18:00 Closing Remarks
Margaret Tongue (Minister-Counsellor Economic Diplomacy, British Embassy Tokyo)
18:00-19:00 Networking Reception

 

Top Research & Recommendations Posts

Back to Events
PageTop